Nalaganje...
Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1
Fibroblast growth factor 2 (FGF-2) is overexpressed in a subset of invasive bladder carcinomas and its overexpression correlates with poor prognosis. Analyses of publicly available databases addressing the molecular mechanisms that may be responsible for the poor prognosis of these tumors, revealed...
Shranjeno v:
| izdano v: | Signal Transduct Target Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5431749/ https://ncbi.nlm.nih.gov/pubmed/28515962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sigtrans.2016.45 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|